A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA) (NCT06510816)

🧪 Interventions in This Study

• Vonaprument (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (132 Sites)

Showing the first 25 of 132 sites.

• Retina Macula Institute of Arizona — Scottsdale, Arizona
• Retina-Vitreous Associates Medical Group — Beverly Hills, California
• Retinal Consultants of Orange County Clinical Research Institute Inc — Fullerton, California
• Global Research Management — Glendale, California
• Retina Consultants Medical Group — Modesto, California
• Northern California Retina Vitreous Associates Medical Group, Inc. — Mountain View, California
• Retinal Consultants Medical Group — Sacramento, California
• Macula Retina Vitreous Research Institute — Torrance, California
• Bay Area Retina Associates — Walnut Creek, California
• Retina Consultants of Southern Colorado PC — Colorado Springs, Colorado
• RSC Research, LLC — Denver, Colorado
• Rand Eye Institute — Deerfield Beach, Florida
• National Ophthalmic Research Institute — Fort Myers, Florida
• Florida Retina Institute — Orlando, Florida
• Fort Lauderdale Eye Institute — Plantation, Florida
• Retina Group of Florida — Sarasota, Florida
• Retina Vitreous Associates of Florida — St. Petersburg, Florida
• East Florida Eye Institute — Stuart, Florida
• Retina Associates of Florida — Tampa, Florida
• Georgia Retina PC — Marietta, Georgia
• Retina Consultants of Hawaii — ‘Aiea, Hawaii
• Retina Associates Ltd — Elmhurst, Illinois
• University Retina — Oak Forest, Illinois
• Springfield Clinic LLP — Springfield, Illinois
• Wolfe Eye Clinic — West Des Moines, Iowa

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Geographic Atrophy

• A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration — Bakersfield, California
• Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy — Phoenix, Arizona
• A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy — Gilbert, Arizona
• Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy — Phoenix, Arizona
• A Study in Adults With Geographic Atrophy — Bakersfield, California

Explore by condition: All Geographic Atrophy clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.